Associated Papers
Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients.
Bhuvaneshwar K et al.
Bmc Cancer, 2019
Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation.
Kumondai M et al.
Drug Metabolism and Pharmacokinetics, 2018
In vitro functional analysis of human cytochrome P450 2A13 genetic variants: P450 2A13*2, *3, *4, and *10.
Kim V et al.
Journal of Toxicology and Environmental Health. Part A, 2018
CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers.
Kumondai M et al.
Biological & Pharmaceutical Bulletin, 2016
Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.
Preissner SC et al.
Plos One, 2013
Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals.
Tamaki Y et al.
Drug Metabolism and Pharmacokinetics, 2011
CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences.
Timofeeva MN et al.
Carcinogenesis, 2009
A bioinformatics approach for the phenotype prediction of nonsynonymous single nucleotide polymorphisms in human cytochromes P450.
Wang LL et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2009
Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.
D'Agostino J et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2008
The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.
Wang SL et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology, 2006
Japanese single nucleotide polymorphism database for 267 possible drug-related genes.
Iida A et al.
Cancer Science, 2006
Genetic polymorphisms of CYP2A13 and its relationship to nasopharyngeal carcinoma in the Cantonese population.
Jiang JH et al.
Journal of Translational Medicine, 2004
Single nucleotide polymorphisms of the human cyp2a13 gene: evidence for a null allele.
Zhang X et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2003
Eighteen novel polymorphisms of the CYP2A13 gene in Japanese.
Fujieda M et al.
Drug Metabolism and Pharmacokinetics, 2003
[SNP collection, pharmacogenomics, and the future of drug therapy].
Iida A et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy, 2002